IMV Debt/Equity
What is the Debt/Equity of IMV?
The Debt/Equity of IMV, Inc. is -5.75
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on TSX compared to IMV
What does IMV do?
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Companies with debt/equity similar to IMV
- Scancell Plc has Debt/Equity of -5.86
- Atlas Technical Consultants has Debt/Equity of -5.86
- Hong Kong Resources has Debt/Equity of -5.80
- Mosaic Brands has Debt/Equity of -5.80
- MEDIAN Technologies SA has Debt/Equity of -5.79
- Shirpur Gold Refinery has Debt/Equity of -5.79
- IMV has Debt/Equity of -5.75
- Ortel Communications has Debt/Equity of -5.75
- Spectra7 Microsystems Inc has Debt/Equity of -5.74
- Goldex Resources has Debt/Equity of -5.73
- Nanoveu has Debt/Equity of -5.71
- ProntoForms has Debt/Equity of -5.70
- T2 Biosystems has Debt/Equity of -5.69